Drug Type Small molecule drug |
Synonyms N-(3,5-bis(trifluoromethyl)benzyl)-3-(3,4,5-trimethoxyphenyl)-1H-pyrazole-5-carboxamide |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Triple Negative Breast Cancer | Preclinical | IN | 01 Nov 2024 | |
Triple Negative Breast Cancer | Preclinical | - | 01 Nov 2024 | |
Triple Negative Breast Cancer | Preclinical | IN | 01 Nov 2024 |